Posts by ericg

Nationally, law firm merger activity is outpacing 2022 and 2021 levels, with 41 completed mergers in the first nine month the year, according to a new report. Read More

A loan on Dartmouth Mall was placed into special servicing earlier this year amid a tough refinancing environment. An updated appraisal puts the retail property’s value at almost half of what it was in 2013. Read More

Shannon O’Brien, the state’s top cannabis regulator who was suspended by State Treasurer Deb Goldberg last month, has put her lawsuit against the treasurer on hold. Read More

Check out Boston’s tech and startup events in October, including Boston Fintech Week, the Tech Breakfast Club, the Techstars Boston fall fireside chat and more. Read More

A Japanese pharmaceutical giant is buying a Boston-London biotech for $387.4 million. Read More

A year after it scored a major win in the form of an FDA approval, a gene therapy firm is retooling things, closing a Lexington research lab amid a 114-person layoff. Read More

Some of the largest Boston-area biotech and pharmaceutical companies are still hoping to net drug approvals from the FDA by the end of 2023. Read More

To address the long-term needs of the industry, we must inspire and equip the next generation of talent by fostering K-12 STEM education in high-need communities, writes Sunny Schwartz of the Massachusetts Biotechnology Education Foundation. Read More

Workplaces need to think proactively about how to support women who are both breadwinners and primary caretakers, or else they may lose out on leadership opportunities. Read More

Millennium Partners founder Christopher Jeffries spoke with the Business Journal about leasing in the Boston office tower — "a lot of activity in the building," but "we’d like to have been further ahead than we are" — and whether its future office towers will also feature passive house design. Read More